Skip to main content

Advertisement

SpringerLink
Log in

Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children

  • Systematic Review/Meta-analysis
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Multiple urinary biomarkers have been reported in differentiation of nonobstructive dilatation (NOD) from ureteropelvic junction obstruction (UPJO). In this meta-analysis, we compared the accuracy of common urinary biomarkers applicable to UPJO. A systematic literature review of electronic databases was conducted for: (UPJO) OR (NOD) AND (urinary biomarkers) AND (children) for articles published in the last decade. PRISMA guidelines were used to exclude duplicate and erroneous articles. Meta-analysis involved risk of bias analysis, heterogeneity assessment, and comparison of sensitivity/specificity by forest plot analysis using MetaXL 5.3. Among the 264 articles analyzed, 19 articles met the inclusion criteria and reported the following: neutrophil gelatinase-associated lipocalin (NGAL), monocyte chemotactic protein-1 (MCP1), carbohydrate antigen 19–9 (CA 19–9), kidney injury molecule (KIM1), epidermal growth factor (EGF), and interferon gamma induced protein-10 (IP10). There was substantial heterogeneity among articles. There was wide variation in applied cut-offs among studies. Overall sensitivity was highest at 87% for CA 19–9 while overall specificity was highest at 76% for NGAL. Overall accuracy was highest at 78% for CA 19–9 followed by 77% for NGAL and 75% for KIM1. In this meta-analysis, the overall accuracy was highest for CA 19–9 followed by NGAL and KIM1. The small number of studies for CA 19–9 and considerable heterogeneity for all should be considered while interpreting these findings. Based on the current meta-analysis, we support a panel of biomarkers combining NGAL, KIM, and CA 19–9 for the best diagnostic accuracy of UPJO in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Cheng H-L (2014) Surgical indications for unilateral neonatal hydronephrosis in considering ureteropelvic junction obstruction. Urol Sci 25:73–76. https://doi.org/10.1016/j.urols.2012.05.002

    Article  Google Scholar 

  2. Passoni NM, Peters CA (2020) Managing ureteropelvic junction obstruction in the young infant. Front Pediatr 8:242. https://doi.org/10.3389/fped.2020.00242

    Article  PubMed  PubMed Central  Google Scholar 

  3. Babu R, Ninan B, Sai V (2018) Evaluating neonates with antenatal hyderonephrosis using a standard protocol: an audit of hospital records. Indian Pediatr 55:966–968. https://doi.org/10.1007/s13312-018-1419-9

    Article  PubMed  Google Scholar 

  4. Babu R, Venkatachalapathy E, Sai V (2019) Hydronephrosis severity score: an objective assessment of hydronephrosis severity in children—a preliminary report. J Pediatr Urol 15:68.e1-68.e6. https://doi.org/10.1016/j.jpurol.2018.09.020

    Article  CAS  Google Scholar 

  5. Lucarelli G, Mancini V, Galleggiante V, Rutigliano M, Vavallo A, Battaglia M, Ditonno P (2014) Emerging urinary markers of renal injury in obstructive nephropathy. Biomed Res Int 2014:303298. https://doi.org/10.1155/2014/303298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jackson L, Woodward M, Coward RJ (2018) The molecular biology of pelvi-ureteric junction obstruction. Pediatr Nephrol 33:553–571. https://doi.org/10.1007/s00467-017-3629-0

    Article  PubMed  Google Scholar 

  7. Washino S, Hosohata K, Miyagawa T (2020) Roles played by biomarkers of kidney injury in patients with upper urinary tract obstruction. Int J Mol Sci 21:5490. https://doi.org/10.3390/ijms21155490

    Article  CAS  PubMed Central  Google Scholar 

  8. Paraboschi I, Mantica G, Dalton NR, Turner C, Garriboli M (2020) Urinary biomarkers in pelvic-ureteric junction obstruction: a systematic review. Transl Androl Urol 9:722–742. https://doi.org/10.21037/tau.2020.01.01

    Article  PubMed  PubMed Central  Google Scholar 

  9. Papachristou F, Pavlaki A, Printza N (2014) Urinary and serum biomarkers in ureteropelvic junction obstruction: a systematic review. Biomarkers 19:531–540. https://doi.org/10.3109/1354750X.2014.943292

    Article  CAS  PubMed  Google Scholar 

  10. Bartoli F, Penza R, Aceto G, Niglio F, D’Addato O, Pastore V, Campanella V, Magaldi S, Lasalandra C, Di Bitonto G, Gesualdo L (2011) Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction. J Pediatr Surg 46:530–536. https://doi.org/10.1016/j.jpedsurg.2010.07.057

    Article  PubMed  Google Scholar 

  11. Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP (2000) MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 58:182–192. https://doi.org/10.1046/j.1523-1755.2000.00153.x

    Article  CAS  PubMed  Google Scholar 

  12. Pavlaki A, Printza N, Farmaki E, Stabouli S, Taparkou A, Sterpi M, Dotis J, Papachristou F (2020) The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants. Pediatr Nephrol 35:163–170. https://doi.org/10.1007/s00467-019-04349-w

    Article  PubMed  Google Scholar 

  13. Alizadeh F, Taefnia AM, Haghdani S (2018) Urinary carbohydrate antigen 19–9/creatinine ratio: a non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children. J Pediatr Urol 14:62.e1-62.e4. https://doi.org/10.1016/j.jpurol.2017.09.012

    Article  Google Scholar 

  14. Keshri R, Govindarajan KK, Rajappa M, Sambandan K, Naredi BK, Jindal B (2021) Can urinary biomarkers be used in the outcome assessment of pyeloplasty in children? Afr J Urol 27:115. https://doi.org/10.1186/s12301-021-00217-y

    Article  Google Scholar 

  15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700–b2700. https://doi.org/10.1136/bmj.b2700

    Article  PubMed  PubMed Central  Google Scholar 

  16. McGuinness LA, Higgins JPT (2021) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Syn Methods 12:55–61. https://doi.org/10.1002/jrsm.1411

    Article  Google Scholar 

  17. Amiri R, Hosseini H, Sanaei Z, Shamahmoudi S, Solgi G (2021) Urinary neutrophil glatinase-associated lipocalin level (uNGAL) may predict the severity of congenital hydronephrosis in infants. Am J Clin Exp Immunol 10:1–7

    PubMed  PubMed Central  Google Scholar 

  18. Yücel ÖB, Dönmez Mİ, Küçükgergin C, Ziylan O, Seçkin Ş, Oktar T (2021) Urinary biomarkers can identify the need for pyeloplasty in presence of supranormal differential renal function in antenatally diagnosed unilateral hydronephrosis. J Pediatr Urol. https://doi.org/10.1016/j.jpurol.2021.08.015

    Article  PubMed  Google Scholar 

  19. Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E (2011) KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol 26:579–586. https://doi.org/10.1007/s00467-011-1773-5

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mohammadjafari H, Rafiei A, Mousavi SA, Alaee A, Yeganeh Y (2014) Role of urinary levels of endothelin-1, monocyte chemotactic peptide-1, and N-acetyl glucosaminidase in predicting the severity of obstruction in hydronephrotic neonates. Korean J Urol 55:670. https://doi.org/10.4111/kju.2014.55.10.670

    Article  PubMed  PubMed Central  Google Scholar 

  21. Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM (2013) Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. J Pediatr Urol 9:838–845. https://doi.org/10.1016/j.jpurol.2012.11.011

    Article  PubMed  Google Scholar 

  22. Taranta-Janusz K, Wasilewska A, Dębek W, Waszkiewicz-Stojda M (2012) Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol 27:2107–2113. https://doi.org/10.1007/s00467-012-2230-9

    Article  PubMed  PubMed Central  Google Scholar 

  23. Nabavizadeh B, Khorramirouz R, Amini E, Pishgar F, Hojjat A, Kajbafzadeh AM (2019) Value of urinary carbohydrate antigen 19–9 to predict failure of conservative management in children with ureteropelvic junction obstruction. J Pediatr Surg 54:1650–1653. https://doi.org/10.1016/j.jpedsurg.2018.09.007

    Article  PubMed  Google Scholar 

  24. Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC (2015) The roles of serum and urinary carbohydrate antigen 19–9 in the management of patients with antenatal hydronephrosis. J Pediatr Urol 11:133.e1-133.e5. https://doi.org/10.1016/j.jpurol.2014.12.012

    Article  Google Scholar 

  25. Kajbafzadeh A-M, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P (2010) Urinary and Serum carbohydrate antigen 19–9 as a biomarker in ureteropelvic junction obstruction in children. J Urol 183:2353–2360. https://doi.org/10.1016/j.juro.2010.02.031

    Article  CAS  PubMed  Google Scholar 

  26. Mohammadjafari H, Rafiei A, Kosaryan M, Yeganeh Y, Hosseinimehr SJ (2014) Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels. Biomark Med 8:1199–1206. https://doi.org/10.2217/bmm.14.79

    Article  CAS  PubMed  Google Scholar 

  27. Li Z, Zhao Z, Liu X, Su Z, Shang X, Wen J (2012) Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF. Pediatr Nephrol 27:2251–2259. https://doi.org/10.1007/s00467-012-2243-4

    Article  PubMed  Google Scholar 

  28. Özkuvancı Ü, Dönmez Mİ, Ziylan O, Oktar T, Küçükgergin C, Çetin B, Erdem S, Seçkin Ş (2020) Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis? J Pediatr Urol 16:844.e1-844.e7. https://doi.org/10.1016/j.jpurol.2020.09.005

    Article  Google Scholar 

  29. Gupta S, Jackson AR, DaJusta DG, McLeod DJ, Alpert SA, Jayanthi VR, McHugh K, Schwaderer AR, Becknell B, Ching CB (2018) Urinary antimicrobial peptides: potential novel biomarkers of obstructive uropathy. J Pediatr Urol 14:238.e1-238.e6. https://doi.org/10.1016/j.jpurol.2018.03.006

    Article  CAS  Google Scholar 

  30. Kostic D, Beozzo GPNS, do Couto SB, Kato AHT, Lima L, Palmeira P, Krebs VLJ, Bunduki V, Francisco RPV, Zugaib M, Dénes FT, de Carvalho WB, Koch VHK (2019) The role of renal biomarkers to predict the need of surgery in congenital urinary tract obstruction in infants. J Pediatr Urol 15:242.e1-242.e9. https://doi.org/10.1016/j.jpurol.2019.03.009

    Article  CAS  Google Scholar 

  31. Bieniaś B, Sikora P (2020) Selected metal matrix metalloproteinases and tissue inhibitors of metalloproteinases as potential biomarkers for tubulointerstitial fibrosis in children with unilateral hydronephrosis. Dis Markers 2020:9520309. https://doi.org/10.1155/2020/9520309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Yu L, Zhou L, Li Q, Li S, Luo X, Zhang C, Wu B, Brooks JD, Sun H (2019) Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction. J Pediatr Urol 15:44.e1-44.e7. https://doi.org/10.1016/j.jpurol.2018.10.007

    Article  CAS  Google Scholar 

  33. Karakus S, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Atar A, Ander H, Ziylan O (2016) Urinary IP-10, MCP-1, NGAL, cystatin-C, and KIM-1 levels in prenatally diagnosed unilateral hydronephrosis: the search for an ideal biomarker. Urology 87:185–192. https://doi.org/10.1016/j.urology.2015.09.007

    Article  PubMed  Google Scholar 

  34. Noyan A, Parmaksiz G, Dursun H, Ezer SS, Anarat R, Cengiz N (2015) Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis. J Pediatr Urol 11:249.e1-249.e6. https://doi.org/10.1016/j.jpurol.2015.02.021

    Article  Google Scholar 

  35. Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM (2012) Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children. Pediatr Nephrol 27:2099–2106. https://doi.org/10.1007/s00467-012-2217-6

    Article  PubMed  Google Scholar 

  36. Radmayr C, Bogaert G, Dogan HS, Kocvara R et al (2019) EAU guidelines on paediatric urology. In: EAU Guidelines, edition presented at the annual EAU Congress Barcelona. EAU

  37. Xie Y, Xue W, Shao X, Che X, Xu W, Ni Z, Mou S (2014) Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes. PLoS ONE 9:e112865. https://doi.org/10.1371/journal.pone.0112865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC (1994) Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 266:F926-933. https://doi.org/10.1152/ajprenal.1994.266.6.F926

    Article  CAS  PubMed  Google Scholar 

  39. Lim AI, Tang SCW, Lai KN, Leung JCK (2013) Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? J Cell Physiol 228:917–924. https://doi.org/10.1002/jcp.24267

    Article  CAS  PubMed  Google Scholar 

  40. Aybek H, Aybek Z, Sinik Z, Demir S, Sancak B, Tuncay L (2006) Elevation of serum and urinary carbohydrate antigen 19–9 in benign hydronephrosis. Int J Urol 13:1380–1384. https://doi.org/10.1111/j.1442-2042.2006.01593.x

    Article  CAS  PubMed  Google Scholar 

  41. Pennemans V, Rigo J-M, Faes C, Reynders C, Penders J, Swennen Q (2013) Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Clin Chem Lab Med 51:1795–1802. https://doi.org/10.1515/cclm-2013-0157

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Nephrology Unit, Sri Ramachandra Institute of Higher Education & Research, Chennai, 600116, India

    Geminiganesan Sangeetha

  2. Pediatric Urology Unit, Sri Ramachandra Institute of Higher Education & Research, 600116, Chennai, India

    Ramesh Babu

Authors
  1. Geminiganesan Sangeetha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ramesh Babu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geminiganesan Sangeetha.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 36 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sangeetha, G., Babu, R. Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children. Pediatr Nephrol 37, 2277–2287 (2022). https://doi.org/10.1007/s00467-022-05488-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-022-05488-3

Keywords

Search

Navigation